Managed aquifer recharge (MAR) is a low-energy subsurface water treatment system with the potential of being an important component of sustainable water reuse schemes. Alongside common wastewater contaminants, MAR systems have been shown to attenuate a range of trace organic chemicals (TOrCs). Despite several factors being possibly important for TOrC attenuation, many have not been investigated in depth. This research effort investigated three factors affecting attenuation of the moderately degradable TOrCs: primary substrate, adaptation of the microbial community to presence of TOrCs, and groundwater temperature. The overall goal was to optimize TOrC attenuation using different MAR configurations considering how these factors affect TOrC attenuation. The primary substrate composition and concentration significantly impacted attenuation of the moderately degradable TOrCs. Lower primary substrate concentrations and more refractory carbon generally resulted in better TOrC transformation, a more diverse microbial community in the infiltration zone and more diverse capabilities for TOrC degradation. The enzyme group cytochrome P450 may be important for TOrC transformation since its genes were more abundant under carbon-starving primary substrate conditions. Adaptation of the microbial community by pre-exposure to TOrCs was not required in order to degrade them. However, adaptation to the primary substrate was necessary for TOrC biotransformation due to its effect on the microbial community. Attenuation of most TOrCs was unaffected by changes in temperature. Some moderately degradable TOrCs, however, were better attenuated at higher temperatures likely due to increased microbial activity. Others were better degraded at lower temperatures likely due to favorable sorption conditions. In the context of applying MAR systems to potential water reuse schemes within Saudi Arabia, a reconnaissance study of TOrC occurrence in treated wastewater effluents was undertaken. Most of the TOrCs targeted were detected at similar concentrations to US effluents at comparable plants. One of the plants studied, however, displayed a significantly different TOrC footprint from the other treatment plants due to the large number of international visitors in its sewershed. Findings from this occurrence study as well from other tasks provided inputs to a risk assessment framework to compare the effectiveness of MAR systems as part of a multiple-barrier water reuse scheme.

Pharmaceuticals, personal care products (PPCPs) and other trace organic contaminants (TOrCs) encompass a diverse group of chemicals that are not currently monitored or regulated in US drinking water or wastewater. Researchers have found low levels of TOrCs in aquatic and terrestrial environments all over the globe, and observed negative effects on impacted biota. The primary source of TOrCs in the environment is domestic wastewater discharges. Centralized wastewater treatment plants present greater risks on a global scale, but on a local scale, onsite treatment systems may have more potent impacts on resources that are invaluable to residents, including groundwater, surface waters, and soils. The objective of this thesis is to identify and characterize promising treatment technologies for onsite TOrC remediation. Receptors who could be impacted by TOrC discharges are assessed, and applications that may require alternative treatment are identified. The best treatment technologies are recognized as those that protect sensitive environmental receptors, provide permanent removal pathways for as many TOrCs as possible, and are not prohibitively expensive to install or maintain. Findings from a pilot study show increased removal of conventional pollutants and TOrCs in an aerobic treatment unit (ATU), two types of biofilter, and a hybrid constructed wetland, all relative to septic tank effluent. The constructed wetland achieved the highest nutrient removals with TN concentrations below 10 mg/L throughout the study. A system with an ATU and peat biofilters achieved the highest removals of persistent pharmaceuticals carbamazepine and lamotrigine (>85% and >95%, respectively). / Master of Science